Abstract:Influenza virus is a respiratory pathogen that causes a high degree of morbidity and mortality every year in multiple parts of the world. Therefore, precise diagnosis of the infecting strain and rapid high-throughput screening of vast numbers of clinical samples is paramount to control the spread of pandemic infections. Current clinical diagnoses of influenza infections are based on serologic testing, polymerase chain reaction, direct specimen immunofluorescence and cell culture (1,2). Here, we report the development of a novel diagnostic technique used to detect live influenza viruses. We used the mouse-adapted human A/PR/8/34 (PR8, H1N1) virus (3) to test the efficacy of this technique using MDCK cells (4). MDCK cells (10(4) or 5 x 10(3) per well) were cultured in 96- or 384-well plates, infected with PR8 and viral proteins were detected using anti-M2 followed by an IR dye-conjugated secondary antibody. M2 (5) and hemagglutinin (1) are two major marker proteins used in many different diagnostic assays. Employing IR-dye-conjugated secondary antibodies minimized the autofluorescence associated with other fluorescent dyes. The use of anti-M2 antibody allowed us to use the antigen-specific fluorescence intensity as a direct metric of viral quantity. To enumerate the fluorescence intensity, we used the LI-COR Odyssey-based IR scanner. This system uses two channel laser-based IR detections to identify fluorophores and differentiate them from background noise. The first channel excites at 680 nm and emits at 700 nm to help quantify the background. The second channel detects fluorophores that excite at 780 nm and emit at 800 nm. Scanning of PR8-infected MDCK cells in the IR scanner indicated a viral titer-dependent bright fluorescence. A positive correlation of fluorescence intensity to virus titer starting from 10(2)-10(5) PFU could be consistently observed. Minimal but detectable positivity consistently seen with 10(2)-10(3) PFU PR8 viral titers demonstrated the high sensitivity of the near-IR dyes. The signal-to-noise ratio was determined by comparing the mock-infected or isotype antibody-treated MDCK cells. Using the fluorescence intensities from 96- or 384-well plate formats, we constructed standard titration curves. In these calculations, the first variable is the viral titer while the second variable is the fluorescence intensity. Therefore, we used the exponential distribution to generate a curve-fit to determine the polynomial relationship between the viral titers and fluorescence intensities. Collectively, we conclude that IR dye-based protein detection system can help diagnose infecting viral strains and precisely enumerate the titer of the infecting pathogens.

Quick Test for the Early Diagnosis of Influenza

Rapid Detection of Influenza A Viruses Using a Real-Time Reverse Transcription Recombinase-Aided Amplification Assay.

A rapid influenza diagnostic test based on detection of viral neuraminidase activity

High-throughput Detection Method for Influenza Virus.

A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009.

[The rapid detection kit based on neuraminidase activity of influenza virus].

Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter

Evaluation of Panel of Neutralising Murine Monoclonal Antibodies and a Humanised Bispecific Antibody Against Influenza A(H1N1)pdm09 Virus Infection in a Mouse Model.

Detection Methods of Human and Animal Influenza Virus—Current Trends

Comparison of a New Gold Immunochromatographic Assay for the Rapid Diagnosis of the Novel Influenza A (H7N9) Virus with Cell Culture and a Real-Time Reverse-Transcription PCR Assay.

High-Throughput cell-based immunofluorescence assays against influenza

Rapid Estimation of Binding Activity of Influenza Virus Hemagglutinin to Human and Avian Receptors

Establishment of a rapid ELISPOT assay for influenza virus titration and neutralizing antibody detection

Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays

Serologic Assays for Influenza Surveillance, Diagnosis and Vaccine Evaluation

Development of a Rapid Test Kit for Detection of Influenza A Virus Specific Nucleoproteins

A Highly Specific ELISA for Diagnosis of 2009 Influenza A (H1N1) Virus Infections.

An Overview of Influenza A Virus Detection Methods: From State-of-the-Art of Laboratories to Point-of-Care Strategies

An ultra-fast thermocycling fluorescence quantitative PCR system for detection of influenza virus:evaluation on its efficacy

A Simple and Rapid Immunochromatographic Strip Test for Detection of Influenza B Viruses

Enhanced detection of infectious airborne influenza virus